Filter by: Subject

Filter by: Subject

Results Per Page:

Tuberculosis (TB) (30)
Mycobacterium tuberculosis (MTB) (18)
South Africa (SA) (14)
Bedaquiline (10)
Drug resistance (7)
Human immunodeficiency virus (HIV) (7)
Multidrug-resistant tuberculosis (MDR-TB) (7)
Drug-resistant tuberculosis (DR-TB) (6)
Drug susceptibility testing (DST) (5)
Extensively drug-resistant tuberculosis (XDR-TB) (5)
Mycobacterium tuberculosis (5)
Clofazimine (4)
Clofazimine (CFZ) (3)
Multidrug-resistant (MDR) (3)
Rifampicin-resistant tuberculosis (3)
SDG-03: Good health and well-being (3)
South Africa (3)
Adults (2)
Anti-infective agents -- South Africa (2)
Antiretroviral therapy (ART) (2)
Bacteria (2)
Drug-resistant tuberculosis (2)
Epidemics (2)
Genome (2)
Human (2)
Infection (2)
KwaZulu-Natal, South Africa (2)
Linezolid (2)
Loss to follow-up (LTFU) (2)
MDR-TB (2)
Minimum inhibitory concentrations (MIC) (2)
Molecular detection (2)
Mutation (2)
Patients (2)
Quality control (QC) (2)
Transmission (2)
Tuberculosis transmission (2)
Whole genome sequencing (WGS) (2)
XDR-TB (2)
24-loci MIRU-VNTR typing (1)
960™ (1)
Abbott RealTime MTB (1)
Acid-fast bacilli (AFB) (1)
Acquired immune deficiency syndrome (AIDS) (1)
Activity space (1)
Advanced HIV disease (1)
Africa (1)
Anti-tuberculosis drugs (1)
Antibiotic-resistant (1)
Antimicrobial resistance (1)
Antimicrobial resistance (AMR) (1)
Antimycobacterials (1)
Antituberculosis therapy (1)
Area under the curve (1)
Assays (1)
AtpE mutations (1)
BACTEC MGIT 960 (1)
Bacteraemia (1)
Bedaquiline (BDQ) (1)
Bias analysis (1)
Biological marker (1)
Broth micro-dilution assay (BMD) (1)
Canonical variant (1)
Carbapenem resistance (1)
CD4+ T lymphocyte (1)
Centre for Tuberculosis (CTB) (1)
Challenges (1)
Critical concentration (CC) (1)
Cross-resistance (1)
Cryptococcosis (1)
Culture conversion (1)
Cut-off value (ECV) (1)
Data quality (1)
Detection system (1)
Diagnostic microbiology -- South Africa (1)
Diagnostice escape (1)
Diagnostics (1)
Disease severity (1)
DNA stability (1)
Draft genome sequence (1)